chrisvoncsefalvay/vaers-outcomes huggingface dataset:
anxious, palpitations, lightheadedness, face,hand numbness, nausea, sweating, tingling hand and face, observed, water given, HR 116, patient taken to ED, no meds given.
Head rush and tingling in hands immediately after but dissipated within 10 minutes, hot flashes throughout day, red rash all over body next morning with pins and needs feelings. Throat swelling causing difficulty swallowing.
on Saturday 10/12/19 patient got the pneumovax23 in right deltoid and a flu shot in the left deltoid. He didn't have any discomfort or signs or symptoms of an adverse reaction until that night, at which time his right arm /elbow became extremely painful to the point he couldn't sleep. He called his doctor but he can't get in to see her until Friday. He showed us today (monday the 14th) at the pharmacy. The right arm /elbow is still red and slightly swollen. His left arm were he got the flu shot has no issues.  He says he is able to move the right armt better today than he could over the weekend. I asked if he had a temperature but he said no. He said after he got a shingles shot last year (at another location) he had a rash on his neck a bruise around his eye. However he has never (and still has not) had any kind of reaction to any flu shot he has gotten to date. He will continue to monitor the area, if it worsens he will seek immediate  medical help, but he said as of today it appears to be getting better.
COOL SENSATION IN MOUTH; TINGLING SENSATION; NUMBNESS; HEAVY CHEST; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1805022) dose was not reported, administered on 06-MAR-2021 10:30 to the left arm for prophylactic vaccination. No concomitant medications were reported.  On 06-MAR-2021 11:00, the patient experienced cool sensation in mouth to the back of the throat (similar to the feeing after eating a peppermint patty). The patient also experienced tingling sensation, numbness from ear to back of the head "like novocaine wearing off", and heavy chest possibly from anxiety or asthma.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from cool sensation in mouth, tingling sensation, numbness, and heavy chest. The reporter assessed the events as related to covid-19 vaccine ad26.cov2.s This report was non-serious.
Information has been received from a registered nurse concerning a male patient who in approximately 2000 was vaccinated with the 1st and 2nd doses of Hepatitis B vaccine recombinant. Subsequently, the patient experienced numbness of the hands and feet. He was vaccinated with a third dose. Medical attention was sought. No further information is available.
got a large red spot at injection site; trace of the irritation site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 70-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 31st December 2019, the patient received Shingles vaccine. On an unknown date, less than a week after receiving Shingles vaccine, the patient experienced injection site erythema and injection site irritation. On an unknown date, the outcome of the injection site erythema and injection site irritation were unknown.   It was unknown if the reporter considered the injection site erythema and injection site irritation to be related to Shingles vaccine.  Additional details were received as follows: The patient after vaccination got a large red spot at the injection site and saw a faint trace of irritation site.
real high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (real high fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PYREXIA (real high fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (real high fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Oct2022 at 16:30 as dose 5 (booster), single (Lot number: GH9693) at the age of 50 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: penicillin" (unspecified if ongoing); "known allergies: all melons" (unspecified if ongoing); "known allergies: bananas" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
the rash on her back, more on the flank area/ the upper arms, she got this rash too; had fever, a low grade fever; 24 hour chills; chills was off and on; This is a spontaneous report from a contactable nurse (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 17Dec2020 03:40 at single dose for COVID-19 immunization. Medical history (Other medications and other medical conditions) reported as no. The patient's concomitant medications were not reported. Caller initially called to "report some side effects after getting covid." Investigation Assessment was No. Consumer (Registered Nurse) further stated Just calling to report side effects because she guessed the data might be needed for study and everything. She went for the vaccine last Thursday (17Dec2020) around 3:40. The first night was the day that she had 24 hour chills (Dec2020). So, just round the clock, Tylenol was taken for that. Then she knew, the rash on her back, more on the flank area that was less than 24 hours that was Friday. And that's in her lower back and now she had more on that lower back and the upper arms, she got this rash too. Chills was off and on. The date when started experiencing rashes was 18Dec2020 and was still experiencing. The patient experienced chills and had fever, a low grade fever (Dec2020), and for chills she took Tylenol. For lab text, the patient stated "About 2 weeks no, after the COVID vaccine no". Due date for the next vaccine shot: Consumer believed the due date for the next vaccine shot was 07Jan2021. The outcome of the event "the rash on her back, more on the flank area/ the upper arms, she got this rash too" was not recovered, of the other events was unknown.
06/06/2019: Cold symptoms. Mild fever, sinus congestion.  06/17/2019: Joint stiffness and inflammation in right ankle, bilateral knees, bilateral hands/fingers, bilateral elbows and back.
red rash on arm at sight of vaccine - itchy . Pain on right arm for 2 days and on and off headaches some blurred vision
Pt presents for Covid 19 vaccination. Pfizer vaccine given per mothers consent. Pt tolerated well. Pt observed in recovery area for 30 min due to history of allergy to Peanuts. Pt did well in recovery and was discharged home with mom. After approx 10 min, pt mother brought pt back into recovery area stating pt had abd pain, shaking and did not feel well. Pt placed in lying position. Sat up to vomit. Vomited small amount. Mother states pt has history of significant anxiety. Pt denies any sob or tingling. Resp easy and unlabored. Pt able to answer questions. A & O x 3. VSS Pulse ox 99 sat. bp 130 /80 hr 60-70. Mother requests EMS to be called. EMS called. Attempt to reassure pt and calm down. No progressive symptoms noted. Pt VSS remain stable. EMS arrives. Pt transported to hospital per EMS per moms request. Dr medical lead called per myself. No medications given. Pt was discharged that day from ED and refered to follow up at hospital
Chief Complaint: Hypoxia. Diagnosed with COVID on 1/6.   Coronavirus pneumonia.  We will start him on moderate dose of steroid as he is requiring 4 L so far.  Increase the dose of steroid accordingly.  He is not a candidate for Remdesivir
little bit of itching on rash in the arm of the injection; rash in right arm; going down from his triceps to his hand in both sides; rash in the left arm of the injection; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (little bit of itching on rash in the arm of the injection) and VACCINATION SITE RASH (rash in the left arm of the injection) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included ALBUTEROL [SALBUTAMOL], CETIRIZINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE RASH (rash in the left arm of the injection). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (little bit of itching on rash in the arm of the injection). The patient was treated with CORTISONE at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (little bit of itching on rash in the arm of the injection) and VACCINATION SITE RASH (rash in the left arm of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The rash in the arm of the injection was 95% resolved, he only had a little bit of itching at the time of report. The a rash on the other right arm, now was 95% resolved at the time of report. For the past 3 weeks (prior to the report)  it had been going down from his triceps to his hand in both sides. He was diagnosed with a dermatological reaction to the vaccine.
This spontaneous report was received from a Doctor of Pharmacy via company representative concerning a 76 year old female patient with allergy to penicillin. The patient's historical conditions were not provided. On 27-JUL-2016, the patient was vaccinated with a dose of ZOSTAVAX 19400 PFU, lot # L046896 (expiry date: 23-FEB-2017) (dose and route were not provided). Concomitant medications were not reported. On 01-AUG-2016, the patient called to the pharmacy to report that she was experiencing redness, itching, and swelling at the injection site since on an unknown date in 2016. Additionally, no rash was reported. The reporter advised the patient to apply ice to the site as a treatment. At the time of the reporting, the patient's outcome concerning redness, itching, and swelling at the injection site was reported as not recovered/not resolved. The causality was not stated. Additional information has been requested.
PATIENT REPORTED CASE OF "COVID ARM" 8 DAYS FOLLOWING VACCINATION. SHE SUDDENLY HAD REDNESS, ITCHING, AND SWELLING AT THE INJECTION SITE. PHARMACIST RECOMMENDED THE PATIENT TO TAKE BENADRYL AND USE AN ICE PACK FOR THE SWELLING. IT WAS RECOMMENDED THAT SHE TRY IBUPROFEN OR NAPROXEN FOR SWELLING AND PAIN BUT PATIENT HAS IBS SO SHE OPTED FOR ACETAMINOPHEN. SHE WAS ALSO TOLD TO CALL BACK WITH ANY CHANGES AND TO USE OPPOSITE ARM FOR HER 2ND DOSE OF THE VACCINE.
felt discomfort at the injection site; felt like she had to support her arm to lift it and it was painful; have some soreness; Pain at the injection site; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 07Jan2021 as single dose for COVID-19 immunization. The patient medical history included, first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 16Dec2020 as single dose for COVID-19 immunization; Flu vaccine (FLU ARIX) for an unspecified indication on an unspecified date in September 2020 or the first of October 2020. Patient's concomitant medications were not reported. Reporter stated that she knew she got her vaccine, Pfizer Covid 19vaccine, for sure, because she felt discomfort at the injection site, she reported that she got her first vaccine on 16Dec2020 and the second vaccine on 07Jan2021. Reporter stated she felt like she had to support her arm to lift it and it was painful and Pain at the injection site. Reporter stated it was almost as bad after the second vaccine. Patient stated that she had experienced this with the Flu vaccine and the brand was Flu Arix. Reporter stated states she had the vaccine in September 2020 or the first of October 2020. Patient stated that the vaccine is mandatory and she generally does have some soreness. The outcome of all the events were unknow.  No Follow-up attempts are needed; information about lot/batch number cannot be obtained.
C/o nausea, numbness, tingling down Left arm, weak, dizzy.  Pt was transferred to Emergency Department for further care and observation.  Vital signs 140/90, HR 74, SpO2 100%.
instant metallic taste in mouth, heaviness in chest, and fast HR.  Taken to ED for further evaluation.
The same day as booster felt chills, fevers for 5 days. Went to the ER and was admitted to hospital. While there had a TIA. Cardiologist has recommended Holter Monitor. Hospital stay was 3 days.
Pt recvd hep B vax on 24NOV89,28DEC89 & 01JUN90.  0n 30JUL90,pt recvd MMR II vax & later lab eval revealed anti-HBs & anti-HBc were positive.
This spontaneous report as received from an other unspecified source refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of improperly store GARDASIL (lot # J003727, expiration date: 07-NOV-2015, dose and route not reported). This is one of several report received from the same source (linked MARRS#s: 1310USA014881, 1310USA014883, 1310USA014888, 1311USA000056, 1311USA000071, 1310USA015417, 1310USA014897, 1311USA000012, 1310USA014858, 1310USA014850, 1310USA014870, 1311USA000289, 1311USA000282, 1310USA014874, 1310USA014861, 1310USA014866, 1310USA014868, 1310USA015422, 1310USA015165, 1311USA000069, 1310USA015424, 1311USA000058, 1311USA000042, 1311USA000013, 1310USA015170, 1311USA000014, 1310USA015153, 1310USA015090, 1311USA000067, 1311USA000064, 1311USA000020, 1311USA000021, 1311USA000040, 1310USA015096, 1311USA000022, 1310USA015101, 1310USA014853, 1311USA000075, 1310USA014895, 1310USA015119, 1310USA015113, 1311USA000059, 1311USA004931, 1311USA000065, 1311USA000739. Additional information has been requested.
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On unknown dates, the patients were administered improperly stored doses of RECOMBIVAX HB lot # M001578 with expiration date 21-NOV-2018 (dose and route of administration not reported). The vaccine underwent a temperature excursion of 0.5 degrees Celsius for 2 hours. Digital Data Logger was involved. There was no previous temperature excursions. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 29Nov2021 17:45 (Batch/Lot number: unknown) at the age of 34 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU), administered in arm left, administration date 29Nov2021 (Batch/Lot number: unknown) as dose 1, single. Relevant medical history included: "Type 1 diabetes" (unspecified if ongoing); "similar reaction to TB test" (unspecified if ongoing), notes: Had similar reaction to TB test at 15 years old. Concomitant medication(s) included: HUMALOG taken for type 1 diabetes mellitus; SKYLA. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left, Vaccine Administration Time: 11:15 AM), administration date: 11Mar2021, when the patient was 33 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left, Vaccine Administration Time: 11:15 AM), administration date: 01Apr2021, when the patient was 33 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 29Nov2021 17:45, outcome "unknown", described as "dose number=3"; MUSCLE SPASMS (non-serious) with onset 30Nov2021 14:00, outcome "not recovered", described as "Full body muscle spasms"; NAUSEA (non-serious) with onset 30Nov2021 14:00, outcome "not recovered", described as "extreme nausea"; DIARRHEA (non-serious) with onset 30Nov2021 14:00, outcome "not recovered", described as "diarrhea"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 30Nov2021 14:00, outcome "not recovered" and all described as "intense muscle and joint pain"; HEADACHE (non-serious) with onset 30Nov2021 14:00, outcome "not recovered", described as "piercing headache". Therapeutic measures were not taken as a result of muscle spasms, nausea, diarrhea, myalgia, arthralgia, headache. Additional information: Prior to vaccination, the patient was not diagnosed with covid-19 and post vaccination, the patient had not been tested for covid-19. The patient did not receive any other vaccine in four weeks. The patient experienced full body muscle spasms, extreme nausea, diarrhea, intense muscle and joint pain, piercing headache on 30Nov2021 14:00 which had been going on for 48 hours and did not seem to be calming down yet. The lot number for bnt162b2 was not provided and will be requested during follow up.
This spontaneous report received from a registered nurse regarding an approximately 16 year old patient of unknown gender. There was no information on pertinent medical history and drug reactions or allergies. The registered nurse reported that patient received doses of GARDASIL (product lot#, expiry date not reported) on 28-OCT-2014, 16-MAR-2015 and 29-APR-2015. No adverse effect had been observed or reported. There was no product quality complaint involved. The outcome of the events was unknown. Additional information has been requested.
No Adverse event; monovalent vaccine for 6 to 11 years old administered instead of bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6 to 11 years old administered instead of bivalent vaccine) and NO ADVERSE EVENT (No Adverse event) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 08-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6 to 11 years old administered instead of bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6 to 11 years old administered instead of bivalent vaccine) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6 to 11 years old administered instead of bivalent vaccine).    Concomitant drugs were not reported. It was reported that the patient received 0.5 ml of the dark blue cap vaccine for 6 to 11 years old instead of the new bivalent vaccine. Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-657547, US-MODERNATX, INC.-MOD-2022-657560 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-657547: US-MODERNATX, INC.-MOD-2022-657560:Same reporter
Next day, Monday 02/21/2019 upper right arm where shot was given was extremely sore and when I got out of bed I was extremely dizzy. Had to return to bed a few hours later. Lasted all day. Tuesday 02/22/2019 and Weds 02/23/2019 mildly dizzy. On Thursday 02/24/2019 I was back to normal health. Called my doctor and she advised me to report side effect to VAERS.
73 year old male with PMHx of AFib, CAD, and HTN who presents with c/o dyspnea that started 4/6/21. Patient states it got to the point where he could not walk in his house without severe dyspnea. States he was diagnosed with COVID-19 one week prior. Per chart review he was in our ER 4/3/21 and diagnosed with COVID-19. At the time he was 95% on room air. His only other symptom has been diarrhea. He states he received the Johnson and Johnson vaccine one month ago. He denies any dizziness, chest pain, abdominal pain, n/v, weakness, or numbness. In ER patient was hypoxic and improved only with BiPAP. Per chart review patient had cardiac arrest on 11/2020 for 17 minutes. He has a significant cardiac history consisting of stemi, fem-pop bypass surgery, PVD, CABG x4, AFib post ablation 2017, V-tach. He was started on therapy with steroids, anticoagulation, and Remdesivir. He failed to improve and had increasing oxygen requirements. He was eventually intubated. Due to failure to improve patient was made DNR and eventually expired.
This spontaneous report as received from a pharmacist via a company representative refers to a 3 patients of unknown age and gender. On an unknown dates, the patients were vaccinated with PNEUMOVAX 23 (dose, route, lot number and expirations dates not reported). In 2014, over the past month, the patients experienced severe injection site reactions. The injection site reactions were treated with antibiotics. At the time of the report the outcome of severe injection site reactions was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
The afternoon after the shot I was fatigued. I had joint aches (including in my ribs) for the following day and a half, I had a headache that was never bad but just lingered despite heavy hydration